Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer-Reference-Cited by-同舟云学术

Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer

Published:1998-12 Issue:6712 Volume:396 Page:699-703
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Pitti Robert M.,Marsters Scot A.,Lawrence David A.,Roy Margaret,Kischkel Frank C.,Dowd Patrick,Huang Arthur,Donahue Christopher J.,Sherwood Steven W.,Baldwin Daryl T.,Godowski Paul J.,Wood William I.,Gurney Austin L.,Hillan Kenneth J.,Cohen Robert L.,Goddard Audrey D.,Botstein David,Ashkenazi Avi

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/25387.pdf

Reference24 articles.

1. Nagata, S. Apoptosis by death factor. Cell 88, 355–365 (1997).

2. Smith, C. A., Farrah, T. & Goodwin, R. G. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 76, 959–962 (1994).

3. Simonet, W. S.et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309–319 (1997).

4. Suda, T., Takahashi, T., Golstein, P. & Nagata, S. Molecular cloning and expression of Fas ligand, a novel member of the TNF family. Cell 75, 1169–1178 (1993).

5. Pennica, D.et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312, 724–729 (1984).

Cited by 677 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting TL1A and DR3: the new frontier of anti-cytokine therapy in IBD;Gut;2024-09-11

2. A comprehensive in silico investigation into the pathogenic SNPs in the RTEL1 gene and their biological consequences;PLOS ONE;2024-09-06

3. Sijunzi decoction enhances sensitivity of colon cancer cells to NK cell destruction by modulating P53 expression;Journal of Ethnopharmacology;2024-07

4. DcR3-associated risk score: correlating better prognosis and enhanced predictive power in colorectal cancer;Discover Oncology;2024-06-19

5. TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis;Med;2024-05